Rapport Therapeutics (RAPP) Capital Expenditures (2023 - 2026)
Rapport Therapeutics' Capital Expenditures came in at $78,000 for Q2 2026, up 254.5% from $22,000 a year earlier but down 9.3% from the prior quarter.
Powered by 
Analysis
Rapport Therapeutics (RAPP) Capital Expenditures (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Rapport Therapeutics reported Capital Expenditures of $467,000, down 31.2% year-over-year; for FY2025, it came in at $616,000, down 74.4% from FY2024.
- Going back by year, Capital Expenditures was $2.41 million in FY2024 (+47.0%) and $1.64 million in FY2023.
- The five-year range for quarterly Capital Expenditures is $22,000 (Q2 2025) to $1.44 million (Q4 2023).
- Year-over-year, Capital Expenditures increased in two of the last eight quarters, with growth averaging 8.6%.
- The fastest year-over-year change in Capital Expenditures over five years came in Q2 2026 (growth of 254.5%), and the weakest in Q2 2025 (a decline of 97.7%).
- Business Quant data shows RAPP's Capital Expenditures at $86,000 (Q1 2026), $169,000 (Q4 2025) and $134,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Rapport Therapeutics | 1.19 Bn | 367.93 Mn | - | 78,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 78,000.00 |
| Mar 31, 2026 | 86,000.00 |
| Dec 31, 2025 | 169,000.00 |
| Sep 30, 2025 | 134,000.00 |
| Jun 30, 2025 | 22,000.00 |
| Mar 31, 2025 | 291,000.00 |
| Dec 31, 2024 | 226,000.00 |
| Sep 30, 2024 | 140,000.00 |
| Jun 30, 2024 | 967,000.00 |
| Mar 31, 2024 | 1.07 Mn |
| Dec 31, 2023 | 1.44 Mn |
| Sep 30, 2023 | 52,000.00 |
API Access
Rapport Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=RAPP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "RAPP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=RAPP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();